Bisphosphonates-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review;Glomérulosclérose segmentaire et focale avec collapsus du flocculus induite par les bisphosphonates ; présentation de deux cas cliniques et revue de la littérature

Nephrologie et Therapeutique

Volumn 5, Issue 2, 2009, Pages 134-138

  Jotterand, Valérie ^a   Moll, Solange ^a   Martin, Pierre Yves ^a   Saudan, Patrick ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Focal segmental glomerulosclerosis; Nephrotic syndrome; Pamidronate; Renal failure

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DOXORUBICIN; PAMIDRONIC ACID; VINCRISTINE;

AGED; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DRUG MEGADOSE; FOCAL GLOMERULOSCLEROSIS; FRACTURE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; PATIENT MONITORING; RISK ASSESSMENT; RISK REDUCTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIPHOSPHONATES; FEMALE; FRACTURES, SPONTANEOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MALE; MULTIPLE MYELOMA; PODOCYTES; RENAL DIALYSIS;

EID: 63349108832     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2008.08.013     Document Type: Article

References (13)

1. Strampel W., Emkey R., and Civitelli R. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf 30 9 (2007) 755-763
2. Markowitz G.S., Appel G.B., Fine P.L., Fenves A.Z., Loon N.R., Jagannath S., et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12 6 (2001) 1164-1172
3. Markowitz G.S., Fine P.L., and D'Agati D.V. Nephrotic syndrome after treatment with pamidronate. Am J Kidney Dis 39 5 (2002) 1118-1122
4. Desikan R., Veksler Y., Raza S., Stokes B., Sabir T., Li Z.J., et al. Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. Br J Haematol 119 2 (2002) 496-499
5. Kunin M., Kopolovic J., Avigdor A., and Holtzman E.J. Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient. Nephrol Dial Transplant 19 3 (2004) 723-726
6. Dijkman H.B., Weening J.J., Smeets B., Verrijp K.C., van Kuppevelt T.H., Assmann K.K., et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 70 2 (2006) 338-344
7. Barri Y.M., Munshi N.C., Sukumalchantra S., Abulezz S.R., Bonsib S.M., Wallach J., et al. Podocyte injury associated glomerulopathies induced by pamidronate. Kidney Int 65 2 (2004) 634-641
8. Bodmer M., Amico P., Mihatsch M.J., Haschke M., Kummer O., Krahenbuhl S., et al. Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient. Nephrol Dial Transplant 22 8 (2007) 2366-2370
9. Korbet S.M. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 9 7 (1998) 1333-1340
10. Schwimmer J.A., Markowitz G.S., Valeri A., and Appel G.B. Collapsing glomerulopathy. Semin Nephrol 23 2 (2003) 209-218
11. D'Agati V.D. The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens 17 3 (2008) 271-281
12. Nasr S.H., Preddie D.C., Markowitz G.S., Appel G.B., and D'Agati V.D. Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes. Kidney Int 69 3 (2006) 616-620
13. Cunningham J. Bisphosphonates in the renal patient. Nephrol Dial Transplant 22 6 (2007) 1505-1507